Flex Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Flex Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About FLKS

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. 

CEO
Frederick E. Pierce, II
CEOFrederick E. Pierce, II
Employees
—
Employees—
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
Founded
Employees
—
Employees—

FLKS Key Statistics

Market cap
2.79M
Market cap2.79M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
—
Dividend yield—
Average volume
93.25K
Average volume93.25K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$50.60
52 Week high$50.60
52 Week low
$1.15
52 Week low$1.15

Stock Snapshot

As of today, Flex Pharma(FLKS) shares are valued at $8.61. The company's market cap stands at 2.79M, with a P/E ratio of -0.02.

Flex Pharma(FLKS) stock opened on 2026-10-18 at —. The price climbed to — and dipped to —.

The Flex Pharma(FLKS)'s current trading volume is 0, compared to an average daily volume of 93.25K.

During the past year, Flex Pharma(FLKS) stock moved between $1.15 at its lowest and $50.60 at its peak.

During the past year, Flex Pharma(FLKS) stock moved between $1.15 at its lowest and $50.60 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.